PortfoliosLab logoPortfoliosLab logo

Sharpe ratio is not yet available for RDUS. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.

How it compares to other similar stocks

The table compares Radius Health, Inc.'s Sharpe Ratio with other stocks in the Drug Manufacturers - Specialty & Generic industry across multiple time periods, showing how RDUS's risk-adjusted performance compares to industry peers.

Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 5, 2026.


SymbolName1Y Sharpe Ratio5Y Sharpe Ratio10Y Sharpe RatioAll Time Sharpe Ratio
INDVIndivior PLC Ordinary Shares4.35
IRWDIronwood Pharmaceuticals, Inc.4.30
BIOABioAge Labs, Inc3.68
VTRSViatris Inc.2.88
AMRXAmneal Pharmaceuticals, Inc.2.77
CURLFCuraleaf Holdings, Inc.2.54
TEVATeva Pharmaceutical Industries Limited2.49
ASRTAssertio Holdings, Inc.2.40
ELANElanco Animal Health Incorporated1.96
SDZNYSandoz Group AG1.82
RDUSRadius Health, Inc.

S&P 500 Index

How to choose period

Historical Sharpe Ratio

The chart shows RDUS's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when RDUS consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.


Loading charts...

Sharpe Ratio Calculator

How does RDUS fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio